# ONGLYZA
> **NDA022350** · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2009-07-31
## Drug
- **FDA Application Number:** NDA022350
- **Application type:** New Drug Application
- **Brand name:** ONGLYZA
- **Generic name:** Saxagliptin Hydrochloride
- **Active ingredients:** SAXAGLIPTIN HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ASTRAZENECA AB
- **First approval:** 2009-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022350)
---
*MORVS · CC0 1.0*